Date: 5th September, 2019
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meeting as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionFriday, 6th September, 2019 DSP , Reliance MF, Motilal Oswal, New
Mark Capital Advisors and otherinvestors
Meeting
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: 7th September, 2019
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETINGS
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meetings as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionMonday, 9th September, 2019 Avendus capital public markets
alternate strategies LLP,UTIMF,Whiteoak capital.
Meeting
Franklin Templeton MF Con-call
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: 16th September, 2019
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meetings as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionTuesday, 17th September, 2019 HSBC MF Con call
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: 17th September, 2019
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meetings as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionWednesday, 18th September,2019
Grandeur Peak Advisors Con-Call or Meeting
The above schedule and mode of interaction is indicative and is subject to changes necessitated by anyunforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: 25th September, 2019
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meetings as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionWednesday, 25th September,2019
Dalton Investment Advisory ServicesPrivate Limited
Con-Call
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: 26th September, 2019
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meeting as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionThursday, 26th September,2019
Chryscapital Meeting
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Date: 30th September, 2019
ToThe Department of Corporate ServicesBSE LimitedPhiroze Jeejeebhoy TowersDalal StreetMumbai- 400001
ToNational Stock Exchange of India LimitedExchange PlazaBandra Kurla ComplexBandra (E)Mumbai-400051
Security Code: 540596 Symbol: ERIS
SUBJECT: INTIMATION OF SCHEDULE OF ANALYST / INSTITUTIONAL INVESTOR MEETING
Dear Sir/Madam,
In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securitiesand Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, we hereby notifythe schedule of Analyst / Institutional Investor Meeting as per table set out below:
Day/Date Fund/Investor/Analyst/Banker Name Mode of interactionMonday, 30th September, 2019 Ashika Stock Broking Meeting
The above schedule is indicative and is subject to changes necessitated by any unforeseen developments.
No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Thanking You,
For Eris Lifesciences Limited
Milind Talegaonkar
Company Secretary & Compliance Officer
Recommended
